Wang Guo-fan, Zhang Bai-jiang, Li Dao-tang, Zhang Xing-guo, Luo Jing-yu, Liu Xi-bin
Department of Thoracic Surgery, Shandong Tumor Hospital & Institute, Jinan 250117, China.
Zhonghua Zhong Liu Za Zhi. 2004 Jan;26(1):55-7.
To evaluate the indications and surgical procedure of bronchial and pulmonary artery sleeve resection for patients with centrally located non-small cell lung cancer, and how to prevent complications.
From July 1989 to Aug 2000, 32 cases of central NSCLC were treated with bronchial and pulmonary arterial sleeve resection and reconstruction. The results were retrospectively analyzed.
The complication rate was 25.0% (8/32), the mortality rate in 30-day postoperation was 6.3% (2/32), the overall 1-, 3- and 5-year survival rate was 82.8% (24/29), 50.0% (11/22) and 33.3% (4/12), respectively.
Bronchial and pulmonary arterial sleeve resection and reconstruction in the treatment of patients with central NSCLC can not only maximize preservation of functional pulmonary parenchyma and improve patients, quality of life, but also provide an opportunity for those patients with poor pulmonary function to receive surgical resection of the tumor.
评估支气管肺动脉袖状切除术治疗中心型非小细胞肺癌患者的适应证、手术方法以及如何预防并发症。
回顾性分析1989年7月至2000年8月采用支气管肺动脉袖状切除重建术治疗的32例中心型非小细胞肺癌患者的临床资料。
并发症发生率为25.0%(8/32),术后30天死亡率为6.3%(2/32),1年、3年和5年总生存率分别为82.8%(24/29)、50.0%(11/22)和33.3%(4/12)。
支气管肺动脉袖状切除重建术治疗中心型非小细胞肺癌不仅能最大限度地保留肺功能实质,提高患者生活质量,还能为肺功能差的患者提供手术切除肿瘤的机会。